DuChemBIO Co.,Ltd.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

www.duchembio.com

Country

South Korea

Exchange

KOSDAQ

Founded 2002

DuChemBIO provides the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson's disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum.

Its portfolio also includes F-DOPA for brain tumor diagnosis with neutralization technology, Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain, and Vizamyl for early diagnosis of beta amyloid in Alzheimer's disease

FES, a solution for diagnosis of metastatic breast cancer and determination of estrogen receptor status. Its portfolio also includes FACBC for prostate cancer diagnosis, FDG for the diagnosis of tumors, and NaF for the diagnosis of bone-related diseases. DuChemBIO Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.

Key Stats

52-Week Range

₩5340.00₩12770.00

Beta0.04

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.